Cargando…

Break CDK2/Cyclin E1 Interface Allosterically with Small Peptides

Most inhibitors of Cyclin-dependent kinase 2 (CDK2) target its ATP-binding pocket. It is difficult, however, to use this pocket to design very specific inhibitors because this catalytic pocket is highly conserved in the protein family of CDKs. Here we report some short peptides targeting a noncataly...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hao, Zhao, Yunjie, Li, Haotian, Zhang, Dongyan, Huang, Yanzhao, Shen, Qi, Van Duyne, Rachel, Kashanchi, Fatah, Zeng, Chen, Liu, Shiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188581/
https://www.ncbi.nlm.nih.gov/pubmed/25290691
http://dx.doi.org/10.1371/journal.pone.0109154
Descripción
Sumario:Most inhibitors of Cyclin-dependent kinase 2 (CDK2) target its ATP-binding pocket. It is difficult, however, to use this pocket to design very specific inhibitors because this catalytic pocket is highly conserved in the protein family of CDKs. Here we report some short peptides targeting a noncatalytic pocket near the interface of the CDK2/Cyclin complex. Docking and molecular dynamics simulations were used to select the peptides, and detailed dynamical network analysis revealed that these peptides weaken the complex formation via allosteric interactions. Our experiments showed that upon binding to the noncatalytic pocket, these peptides break the CDK2/Cyclin complex partially and diminish its kinase activity in vitro. The binding affinity of these peptides measured by Surface Plasmon Resonance can reach as low as 0.5 µM.